IL6 and chronic kidney disease: In CKD, chronic inflammation activates pro-inflammatory pathways, including nuclear factor-kappa B (NF-κB) and interleukin-6 (IL-6) signaling, driving oxidative stress and endothelial dysfunction [46,47].